2,670
Views
4
CrossRef citations to date
0
Altmetric
Articles

Characteristics and outcomes of COVID-19 patients with and without asthma from the United States, South Korea, and Europe

, PhDORCID Icon, , MD, , PhD, , BS, , PhD, , PhDORCID Icon, , PhDORCID Icon, , PhD, , PhD, , MSc, , PhDORCID Icon, , MD, , MD, , MSc, , Mph, , Dphil, , Msc, , PhD, , PhD, , PhD, , MD, , PhD, , PhD, , MD, , MD, , PhD, , MD, , Mph, , PhD, , PhD, , PhD, , PhD, , MD, , PhD, , PhD, , MD, , PhD, , PhD, , PhD & , Mph show all
Pages 76-86 | Received 02 Aug 2021, Accepted 30 Dec 2021, Published online: 11 Feb 2022

References

  • Sears MR. Epidemiology of asthma exacerbations. J Allergy Clin Immunol. 2008;122(4):662–668. doi:10.1016/j.jaci.2008.08.003.
  • Wark PA, Tooze M, Powell H, Parsons K. Viral and bacterial infection in acute asthma and chronic obstructive pulmonary disease increases the risk of readmission. Respirology. 2013;18(6):996–1002. doi:10.1111/resp.12099.
  • Ko FW-S, Chan PK-S, Chan RWY, Chan K-P, Ip A, Kwok A, Ngai JC-L, Ng S-S, On CT, Hui DS-C, et al. Molecular detection of respiratory pathogens and typing of human rhinovirus of adults hospitalized for exacerbation of asthma and chronic obstructive pulmonary disease. Respir Res. 2019;20(1):210. doi:10.1186/s12931-019-1181-0.
  • British Thoracic Society. BTS guidance for health care professionals in relation to shielding. 2020. https://www.brit-thoracic.org.uk/about-us/covid-19-identifying-patients-for-shielding/ Accessed 22/09/20.
  • Trinh P, Jung TH, Keene D, Demmer RT, Perzanowski M, Lovasi G. Temporal and spatial associations between influenza and asthma hospitalisations in New York City from 2002 to 2012: a longitudinal ecological study. BMJ Open. 2018;8(9):e020362. doi:10.1136/bmjopen-2017-020362.
  • Puig-Barberà J, Natividad-Sancho A, Trushakova S, Sominina A, Pisareva M, Ciblak MA, Badur S, Yu H, Cowling BJ, El Guerche-Séblain C, Global Influenza Hospital Surveillance Study Group (GIHSN), et al. Epidemiology of hospital admissions with Influenza during the 2013/2014 Northern Hemisphere Influenza Season: results from the Global Influenza Hospital Surveillance Network. PLoS One. 2016;11(5):e0154970 doi:10.1371/journal.pone.0154970
  • Wang H, Song J, Yao Y, Deng Y‐K, Wang Z‐C, Liao B, Ma J, He C, Pan L, Liu Y, et al. Angiotensin-converting enzyme II expression and its implication in the association between COVID-19 and allergic rhinitis [published online ahead of print, 2020 Aug 27]. Allergy. 2021;76(3):906–910. doi:10.1111/all.14569.
  • Shi W, Gao Z, Ding Y, Zhu T, Zhang W, Xu Y. Clinical characteristics of COVID-19 patients combined with allergy. Allergy. 2020;75(9):2405–2408. doi:10.1111/all.14434
  • Halpin DMG, Singh D, Hadfield RM. Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective. Eur Respir J. 2020;55(5):2001009 (Published 2020 May 7. doi:10.1183/13993003.01009-2020.
  • Burn E, You SC, Sena AG, Kostka K, Abedtash H, Abrahão MTF, Alberga A, Alghoul H, Alser O, Alshammari TM, et al. Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study. Nat Commun. 2020;11(1):5009. doi:10.1038/s41467-020-18849-z.
  • Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, Curtis HJ, Mehrkar A, Evans D, Inglesby P, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430–436. doi:10.1038/s41586-020-2521-4
  • Chhiba KD, Patel GB, Vu THT, Chen MM, Guo A, Kudlaty E, Mai Q, Yeh C, Muhammad LN, Harris KE, et al. Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19. J Allergy Clin Immunol. 2020;146(2):307–314.e4. doi:10.1016/j.jaci.2020.06.010
  • Lovinsky-Desir S, Deshpande DR, De A, et al. Asthma among hospitalized patients with COVID-19 and related outcomes [published online ahead of print, 2020 Aug 6]. J Allergy Clin Immunol. 2020;S0091–6749(20):31100–31103. doi:10.1016/j.jaci.2020.07.026.
  • Beurnier A, Jutant E-M, Jevnikar M, Boucly A, Pichon J, Preda M, Frank M, Laurent J, Richard C, Monnet X, et al. Characteristics and outcomes of asthmatic patients with COVID-19 pneumonia who require hospitalisation [published online ahead of print, 2020 Jul 30]. Eur Respir J. 2020;56(5):2001875. doi:10.1183/13993003.01875-2020.
  • Grandbastien M, Piotin A, Godet J, Abessolo-Amougou I, Ederlé C, Enache I, Fraisse P, Tu Hoang TC, Kassegne L, Labani A, et al. SARS-CoV-2 pneumonia in hospitalized asthmatic patients did not induce severe exacerbation. J Allergy Clin Immunol Pract. 2020;8(8):2600–2607. doi:10.1016/j.jaip.2020.06.032.
  • Voss EA, Makadia R, Matcho A, Ma Q, Knoll C, Schuemie M, DeFalco FJ, Londhe A, Zhu V, Ryan PB, et al. Feasibility and utility of applications of the common data model to multiple, disparate observational health databases. J Am Med Inform Assoc. 2015;22(3):553–564. doi:10.1093/jamia/ocu023.
  • Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, Suchard MA, Park RW, Wong IC, Rijnbeek PR, et al. Observational health data sciences and informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574–578.
  • Sena A, Kostka K, Schuemie M, Posada JD. ohdsi-studies/Covid19CharacterizationCharybdis: Charybdis v1.1.1-Publication Package (Version v1.1.1). Zenodo. 2020. doi:10.5281/zenodo.4033034.
  • Datta S, Posada J, Olson G, et al. A new paradigm for accelerating clinical data science at Stanford Medicine. Published Online March 17. http://arxiv.org/abs/2003.10534 (Accessed Aug 20, 2020).
  • Del Mar García-Gil M, Hermosilla E, Prieto-Alhambra D, et al. Construction and validation of a scoring system for the selection of high-quality data in a Spanish population primary care database (SIDIAP). Inform Prim Care. 2012;19:135–145.
  • Engelkes M, de Ridder MA, Svensson E, Berencsi K, Prieto-Alhambra D, Lapi F, Giaquinto C, Picelli G, Boudiaf N, Albers FC, et al. Multinational cohort study of mortality in patients with asthma and severe asthma. Respir Med. 2020;Apr–May165:105919. doi:10.1016/j.rmed.2020.105919.
  • Herrett E, Gallagher AM, Bhaskaran K, Forbes H, Mathur R, van Staa T, Smeeth L. Data resource profile: clinical practice research datalink (CPRD). Int J Epidemiol. 2015;44(3):827–836. doi:10.1093/ije/dyv098.
  • Austin PC. Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research. Commun Stat Simul Comput. 2009;38(6):1228–1234. doi:10.1080/03610910902859574.
  • Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. doi:10.1016/S0140-6736(20)30211-7.
  • Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020;146(1):110–118. doi:10.1016/j.jaci.2020.04.006.
  • Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK, Greninger AL, Pipavath S, Wurfel MM, Evans L, et al. Covid-19 in critically ill patients in the Seattle region – case series. N Engl J Med. 2020;382(21):2012–2022. doi:10.1056/NEJMoa2004500.
  • Garg S. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019—COVID-NET, 14 states, March 1–30, 2020. MMWR Morb Mortal Wkly Rep. 2020:69.
  • Myers LC, Parodi SM, Escobar GJ, Liu VX. Characteristics of hospitalized adults with COVID-19 in an integrated health care system in California. JAMA. 2020;323(21):2195–2198. doi:10.1001/jama.2020.7202.
  • Brusselle GG, Ko FW. Prevalence and burden of asthma in China: time to act. Lancet. 2019;394(10196):364–366. doi:10.1016/S0140-6736(19)31349-2.
  • The Global Asthma Report. 2018. http://www.globalasthmareport.org/burden/burden.php. Accessed 30/09/2020.
  • Centres for Disease Control and Prevention (CDC). COVID-19 hospitalization and death by age. https://www.cdc.gov/coronavirus/2019-ncov/covid-data/investigations-discovery/hospitalization-death-by-age.html. Accessed 16 Sep 2020.
  • Weatherburn CJ, Guthrie B, Mercer SW, Morales DR. Comorbidities in adults with asthma: population-based cross-sectional analysis of 1.4 million adults in Scotland. Clin Exp Allergy. 2017;Oct47(10):1246–1252. doi:10.1111/cea.12971.
  • Morales DR, Lipworth BJ, Donnan PT, Jackson C, Guthrie B. Respiratory effect of beta-blockers in people with asthma and cardiovascular disease: population-based nested case control study. BMC Med. 2017;Jan 15(1):18. doi:10.1186/s12916-017-0781-0.
  • Morales DR, Dreischulte T, Lipworth BJ, Donnan PT, Jackson C, Guthrie B. Respiratory effect of beta-blocker eye drops in asthma: population-based study and meta-analysis of clinical trials. Br J Clin Pharmacol. 2016;Sep82(3):814–822. doi:10.1111/bcp.13006.
  • Morales DR, Lipworth BJ, Guthrie B, Jackson C, Donnan PT, Santiago VH. Safety risks for patients with aspirin-exacerbated respiratory disease after acute exposure to selective nonsteroidal anti-inflammatory drugs and COX-2 inhibitors: meta-analysis of controlled clinical trials. J Allergy Clin Immunol. 2014;Jul134(1):40–45. doi:10.1016/j.jaci.2013.10.057.
  • Recalde M, Roel E, Pistillo A, et al. Characteristics and outcomes of 627 044 COVID-19 patients with and without obesity in the United States, Spain, and the United Kingdom. Int J Obes. 2021;45(11):2347–2357. doi:10.1101/2020.09.02.2018517.